Table 2.
The association of obesity/overweight with RCC risk by stratification of estrogen status.
| Pre-menopausal |
Post-menopausal |
||||||
|---|---|---|---|---|---|---|---|
| Case |
Control |
P value |
Case |
Control |
P value |
||
| (n = 165) | (n = 192) | (n = 280) | (n = 316) | ||||
| BMI | 0.029 | 0.193 | |||||
| (n, %) | <25 | 111 (67.27) | 149 (77.60) | 159 (56.79) | 196 (62.03) | ||
| ≥25 | 54 (32.73) | 43 (22.40) | 121 (43.21) | 120 (37.97) | |||
| WC | |||||||
| (n, %) | quartile1 | 54 (32.73) | 80 (41.67) | 0.001 | 40 (14.29) | 64 (20.25) | 0.072 |
| quartile2 | 31 (18.78) | 58 (30.21) | 63 (22.50) | 85 (26.90) | |||
| quartile3 | 44 (26.67) | 32 (16.67) | 86 (30.71) | 79 (25.00) | |||
| quartile4 | 36 (21.82) | 22 (11.45) | 91 (32.50) | 88 (27.85) | |||
BMI: Body Mass Index; WC: Waist Circumference; RCC: renal cell carcinoma.